Investing in Alnylam Pharmaceuticals, Inc.? If so, we recommend checking out these offers as well (we believe these to be much more interesting):
Cannabis Trader: https://logistics-business-review.com/cannabis-trader-for-ALNY-investors
Trade Netflix: https://logistics-business-review.com/netflix-for-ALNY-investors
Wall Street Journal: https://logistics-business-review.com/wsj-for-ALNY-investors (only $12 for 12 weeks – everyone should get this)
REPORTING FOR 2019-07-29 | LOGISTICS-BUSINESS-REVIEW.COM: We have conducted a deep analysis of how Alnylam Pharmaceuticals, Inc. ($ALNY) has been trading over the last 2 weeks and the past day especially. On its latest session, Alnylam Pharmaceuticals, Inc. ($ALNY) opened at 74.46, reaching a high of 76.5 and a low of 73.875 before closing at a price of 76.36. There was a total volume of 346719.
VOLUME INDICATORS: We saw an accumulation-distribution index of 1840.82054, an on-balance volume of -74.14, chaikin money flow of 1.57353 and a force index of 0.135. There was an ease of movement rating of -0.00233, a volume-price trend of -2.76292 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 1.95863, bolinger bands of 74.29554, an upper bollinger band of 72.99446, lower bollinger band of 73.875, a bollinger high band indicator of 1.0, bollinger low band indicator of 1.0, a central keltner channel of 74.945, high band keltner channel of 72.905, low band keltner channel of 76.985, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 73.875, a donchian channel low band of 73.875, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of -0.01032, a MACD signal of -0.00573, a MACD difference of -0.00459, a fast Exponential Moving Average (EMA) indicator of 73.875, a slow Exponential Moving Average (EMA) indicator of 73.875, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.60303, a trix of -0.44897, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of 2.86716, a KST Oscillator (KST) of -37.36089 and a KST Oscillator (KST Signal) of -37.36089 (leaving a KST difference of -1.49852). We also found an Ichimoku rating of 75.48, an Ichimoku B rating of 75.48, a Ichimoku visual trend A of 78.21495, an Ichimoku visual trend B of 76.56957, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of -4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 34.06703, a True Strength Index (TSI) of -100.0, an ultimate oscillator of -1084.01644, a stochastic oscillator of 128.67647, a stochastic oscillator signal of 128.67647, a Williams %R rating of 28.67647 and an awesome oscillator of 0.18008.
RETURNS: There was a daily return of -3.73609, a daily log return of -0.62462 and a cumulative return of -0.62267.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-29 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for Alnylam Pharmaceuticals, Inc. ($ALNY)…
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on Alnylam Pharmaceuticals, Inc., we strongly advise Alnylam Pharmaceuticals, Inc. investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like Alnylam Pharmaceuticals, Inc. – without this you are trading blind:
We will of course continue to cover the news and price action of Alnylam Pharmaceuticals, Inc., but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Alnylam Pharmaceuticals, Inc. ($ALNY) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.